Bionano Genomics Statistics Share Statistics Bionano Genomics has 3.36M
shares outstanding. The number of shares has increased by -0.05%
in one year.
Shares Outstanding 3.36M Shares Change (YoY) -0.05% Shares Change (QoQ) 0% Owned by Institutions (%) 3.73% Shares Floating 3.35M Failed to Deliver (FTD) Shares 96 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 706.38K, so 7.3% of the outstanding
shares have been sold short.
Short Interest 706.38K Short % of Shares Out 7.3% Short % of Float 7.3% Short Ratio (days to cover) 1.14
Valuation Ratios The PE ratio is -0.29 and the forward
PE ratio is -0.52.
Bionano Genomics's PEG ratio is
0.
PE Ratio -0.29 Forward PE -0.52 PS Ratio 1.07 Forward PS 0.2 PB Ratio 0.93 P/FCF Ratio -0.48 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Bionano Genomics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.06,
with a Debt / Equity ratio of 0.77.
Current Ratio 1.06 Quick Ratio 0.76 Debt / Equity 0.77 Debt / EBITDA -0.28 Debt / FCF -0.4 Interest Coverage -359.8
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $314.04K Profits Per Employee $-1.14M Employee Count 98 Asset Turnover 0.4 Inventory Turnover 2.73
Taxes Income Tax 33K Effective Tax Rate -0.03%
Stock Price Statistics The stock price has increased by -93.04% in the
last 52 weeks. The beta is 2.2, so Bionano Genomics's
price volatility has been higher than the market average.
Beta 2.2 52-Week Price Change -93.04% 50-Day Moving Average 3.02 200-Day Moving Average 4.9 Relative Strength Index (RSI) 36.98 Average Volume (20 Days) 565,471
Income Statement In the last 12 months, Bionano Genomics had revenue of 30.78M
and earned -112.02M
in profits. Earnings per share was -88.13.
Revenue 30.78M Gross Profit 380K Operating Income -103.98M Net Income -112.02M EBITDA -97.47M EBIT -111.69M Earnings Per Share (EPS) -88.13
Full Income Statement Balance Sheet The company has 9.17M in cash and 27.3M in
debt, giving a net cash position of -18.12M.
Cash & Cash Equivalents 9.17M Total Debt 27.3M Net Cash -18.12M Retained Earnings -693.23M Total Assets 76.01M Working Capital 18.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -68.92M
and capital expenditures -103K, giving a free cash flow of -69.03M.
Operating Cash Flow -68.92M Capital Expenditures -103K Free Cash Flow -69.03M FCF Per Share -36.28
Full Cash Flow Statement Margins Gross margin is 1.23%, with operating and profit margins of -337.87% and -363.98%.
Gross Margin 1.23% Operating Margin -337.87% Pretax Margin -363.87% Profit Margin -363.98% EBITDA Margin -316.7% EBIT Margin -337.87% FCF Margin -224.28%
Dividends & Yields BNGO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BNGO is $8,
which is 316.7% higher than the current price. The consensus rating is "Hold".
Price Target $8 Price Target Difference 316.7% Analyst Consensus Hold Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 27, 2025. It was a
backward
split with a ratio of 1:60.
Last Split Date Jan 27, 2025 Split Type backward Split Ratio 1:60
Scores Altman Z-Score -15.75 Piotroski F-Score 4
